Linaclotide API - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Chemical & Material > Linaclotide API - Global Top Players Market Share and Ranking 2025

Linaclotide API - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-09
Report Id: 2861295
Industry: Chemical & Material
Report Page: 112
Chart: 113

PDF Download

Publication Date: 2025-12-09
Report Id: 2861295
Industry: Chemical & Material
Report Page: 112
Chart: 113

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Linaclotide API Definition
1.2 Global Linaclotide API Market Size and Forecast
1.2.1 By Consumption Value, Global Linaclotide API Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Linaclotide API Market Size, 2020-2031
1.2.3 Global Linaclotide API Average Selling Price (ASP), 2020-2031
1.3 China Linaclotide API Market Size and Forecast
1.3.1 By Consumption Value, China Linaclotide API Market Size, 2020-2031
1.3.2 By Sales Quantity, China Linaclotide API Market Size, 2020-2031
1.3.3 China Linaclotide API Average Selling Price (ASP), 2020-2031
1.4 Share of China Linaclotide API Market with Respect to the Global Market
1.4.1 By Consumption Value, China Linaclotide API Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Linaclotide API Market Share in Global, 2020-2031
1.4.3 Linaclotide API Market Size: China VS Global, 2020-2031
1.5 Linaclotide API Market Dynamics
1.5.1 Linaclotide API Market Drivers
1.5.2 Linaclotide API Market Restraints
1.5.3 Linaclotide API Industry Trends
1.5.4 Linaclotide API Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Linaclotide API, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Linaclotide API, Global Market Share by Company, 2020-2025
2.3 Linaclotide API Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Linaclotide API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Linaclotide API Concentration Ratio
2.6 Global Linaclotide API Mergers & Acquisitions, Expansion Plans
2.7 Global Linaclotide API Manufacturers Product Type
2.8 Head Office and Linaclotide API Production Site of Key Manufacturer
2.9 Linaclotide API Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Linaclotide API, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Linaclotide API, China Market Share by Company, 2020-2025
3.3 China Linaclotide API Linaclotide API Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Linaclotide API Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Linaclotide API Capacity by Region
4.3 Global Linaclotide API Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Linaclotide API Production by Region, 2020-2031
4.5 Global Linaclotide API Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Linaclotide API Industry Chain
5.2 Linaclotide API Upstream Analysis
5.2.1 Linaclotide API Core Raw Materials
5.2.2 Main Manufacturers of Linaclotide API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Linaclotide API Production Mode
5.6 Linaclotide API Procurement Model
5.7 Linaclotide API Industry Sales Model and Sales Channels
5.7.1 Linaclotide API Sales Model
5.7.2 Linaclotide API Typical Distributors

6 Sights by Type
6.1 Linaclotide API Classification by Type
6.1.1 High Purity
6.1.2 Standard Purity
6.2 by Type, Global Linaclotide API Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Linaclotide API Consumption Value, 2020-2031
6.4 by Type, Global Linaclotide API Sales Quantity, 2020-2031
6.5 by Type, Global Linaclotide API Average Selling Price (ASP), 2020-2031

7 Sights by Production Model
7.1 Linaclotide API Classification by Production Model
7.1.1 In-House Manufactured API
7.1.2 CDMO Contract Production API
7.1.3 Others
7.2 by Production Model, Global Linaclotide API Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Production Model, Global Linaclotide API Consumption Value, 2020-2031
7.4 by Production Model, Global Linaclotide API Sales Quantity, 2020-2031
7.5 by Production Model, Global Linaclotide API Average Selling Price (ASP), 2020-2031

8 Sights by Therapeutic Area
8.1 Linaclotide API Classification by Therapeutic Area
8.1.1 Chronic Constipation Treatment
8.1.2 IBS-C Treatment
8.1.3 Others
8.2 by Therapeutic Area, Global Linaclotide API Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Therapeutic Area, Global Linaclotide API Consumption Value, 2020-2031
8.4 by Therapeutic Area, Global Linaclotide API Sales Quantity, 2020-2031
8.5 by Therapeutic Area, Global Linaclotide API Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Linaclotide API Segment by Application
9.1.1 Pharmaceutical Companies
9.1.2 Research Institutes
9.1.3 Others
9.2 by Application, Global Linaclotide API Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Linaclotide API Consumption Value, 2020-2031
9.4 by Application, Global Linaclotide API Sales Quantity, 2020-2031
9.5 by Application, Global Linaclotide API Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Linaclotide API Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Linaclotide API Consumption Value, 2020-2031
10.3 By Region, Global Linaclotide API Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Linaclotide API Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Linaclotide API Market Size Market Share
10.5 Europe
10.5.1 Europe Linaclotide API Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Linaclotide API Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Linaclotide API Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Linaclotide API Market Size Market Share
10.7 South America
10.7.1 South America Linaclotide API Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Linaclotide API Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Linaclotide API Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Linaclotide API Consumption Value, 2020-2031
11.3 By Country, Global Linaclotide API Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Linaclotide API Market Size, 2020-2031
11.4.2 by Type, United States Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Linaclotide API Market Size, 2020-2031
11.5.2 by Type, Europe Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Linaclotide API Market Size, 2020-2031
11.6.2 by Type, China Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Linaclotide API Market Size, 2020-2031
11.7.2 by Type, Japan Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Linaclotide API Market Size, 2020-2031
11.8.2 by Type, South Korea Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Linaclotide API Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Linaclotide API Market Size, 2020-2031
11.10.2 by Type, India Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Linaclotide API Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Linaclotide API Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Linaclotide API Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Piramal Pharma Solutions
12.1.1 Piramal Pharma Solutions Company Information, Head Office, Market Area, and Industry Position
12.1.2 Piramal Pharma Solutions Linaclotide API Models, Specifications, and Application
12.1.3 Piramal Pharma Solutions Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Piramal Pharma Solutions Company Profile and Main Business
12.1.5 Piramal Pharma Solutions Recent Developments
12.2 Neuland Labs
12.2.1 Neuland Labs Company Information, Head Office, Market Area, and Industry Position
12.2.2 Neuland Labs Linaclotide API Models, Specifications, and Application
12.2.3 Neuland Labs Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Neuland Labs Company Profile and Main Business
12.2.5 Neuland Labs Recent Developments
12.3 TAPI
12.3.1 TAPI Company Information, Head Office, Market Area, and Industry Position
12.3.2 TAPI Linaclotide API Models, Specifications, and Application
12.3.3 TAPI Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 TAPI Company Profile and Main Business
12.3.5 TAPI Recent Developments
12.4 ChemWerth
12.4.1 ChemWerth Company Information, Head Office, Market Area, and Industry Position
12.4.2 ChemWerth Linaclotide API Models, Specifications, and Application
12.4.3 ChemWerth Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 ChemWerth Company Profile and Main Business
12.4.5 ChemWerth Recent Developments
12.5 Omgene Life Sciences
12.5.1 Omgene Life Sciences Company Information, Head Office, Market Area, and Industry Position
12.5.2 Omgene Life Sciences Linaclotide API Models, Specifications, and Application
12.5.3 Omgene Life Sciences Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Omgene Life Sciences Company Profile and Main Business
12.5.5 Omgene Life Sciences Recent Developments
12.6 BCN Peptides
12.6.1 BCN Peptides Company Information, Head Office, Market Area, and Industry Position
12.6.2 BCN Peptides Linaclotide API Models, Specifications, and Application
12.6.3 BCN Peptides Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 BCN Peptides Company Profile and Main Business
12.6.5 BCN Peptides Recent Developments
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position
12.7.2 Aurobindo Pharma Linaclotide API Models, Specifications, and Application
12.7.3 Aurobindo Pharma Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Aurobindo Pharma Company Profile and Main Business
12.7.5 Aurobindo Pharma Recent Developments
12.8 Zhejiang Peptites Biotech
12.8.1 Zhejiang Peptites Biotech Company Information, Head Office, Market Area, and Industry Position
12.8.2 Zhejiang Peptites Biotech Linaclotide API Models, Specifications, and Application
12.8.3 Zhejiang Peptites Biotech Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Zhejiang Peptites Biotech Company Profile and Main Business
12.8.5 Zhejiang Peptites Biotech Recent Developments
12.9 Suzhou Tianma Pharma Group
12.9.1 Suzhou Tianma Pharma Group Company Information, Head Office, Market Area, and Industry Position
12.9.2 Suzhou Tianma Pharma Group Linaclotide API Models, Specifications, and Application
12.9.3 Suzhou Tianma Pharma Group Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 Suzhou Tianma Pharma Group Company Profile and Main Business
12.9.5 Suzhou Tianma Pharma Group Recent Developments
12.10 Chinese Peptide Company
12.10.1 Chinese Peptide Company Company Information, Head Office, Market Area, and Industry Position
12.10.2 Chinese Peptide Company Linaclotide API Models, Specifications, and Application
12.10.3 Chinese Peptide Company Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 Chinese Peptide Company Company Profile and Main Business
12.10.5 Chinese Peptide Company Recent Developments
12.11 Zhejiang Supor Pharmaceuticals
12.11.1 Zhejiang Supor Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.11.2 Zhejiang Supor Pharmaceuticals Linaclotide API Models, Specifications, and Application
12.11.3 Zhejiang Supor Pharmaceuticals Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Zhejiang Supor Pharmaceuticals Company Profile and Main Business
12.11.5 Zhejiang Supor Pharmaceuticals Recent Developments
12.12 Hybio Pharmaceutical
12.12.1 Hybio Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
12.12.2 Hybio Pharmaceutical Linaclotide API Models, Specifications, and Application
12.12.3 Hybio Pharmaceutical Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Hybio Pharmaceutical Company Profile and Main Business
12.12.5 Hybio Pharmaceutical Recent Developments
12.13 ChengDu ShengNuo Biotec
12.13.1 ChengDu ShengNuo Biotec Company Information, Head Office, Market Area, and Industry Position
12.13.2 ChengDu ShengNuo Biotec Linaclotide API Models, Specifications, and Application
12.13.3 ChengDu ShengNuo Biotec Linaclotide API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 ChengDu ShengNuo Biotec Company Profile and Main Business
12.13.5 ChengDu ShengNuo Biotec Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Linaclotide API should grow from US$ 119 million in 2024 to US$ 168 million by 2031, with a CAGR of 4.8% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Linaclotide API

According to YH Research, the global market for Linaclotide API should grow from US$ 119 million in 2024 to US$ 168 million by 2031, with a CAGR of 4.8% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Linaclotide API is a high-purity peptide active pharmaceutical ingredient used in therapies for irritable bowel syndrome with constipation (IBS-C) and related gastrointestinal disorders. Its upstream inputs include amino acid monomers (standard and protected), coupling and protection/deprotection reagents, solid-phase resins or liquid-phase synthesis consumables, solvents, chromatographic media and other purification consumables, together with lyophilization, sterile/clean packaging and rigorous analytical QC equipment. Downstream customers primarily consist of innovator and generic drug manufacturers, formulation CDMOs/CMOs, finished-dosage manufacturers and clinical research organizations. The global production capacity for linaclotide API in 2024 is roughly 3.5 metric tons with sales around 3.2 metric tons, an average ex-works price near USD 35,000/kg and an implied market value of approximately USD 42 million; typical supplier gross margins are in the 30%–45% range, with higher premiums for customized lots and regulatory-compliant batches. Owing to multiple synthesis steps, stringent purification and lyophilization requirements, linaclotide API sits in a high-value, low-volume, high-barrier niche whose market dynamics are driven by therapeutic demand, patent and generic entry timing, regulatory approvals, and CDMO capacity and compliance.

The current market for linaclotide API is experiencing steady expansion, driven primarily by increasing global clinical demand for treatments related to IBS-C and chronic functional constipation. Aging demographics, lifestyle changes, and dietary shifts have contributed to a larger patient base, while evolving reimbursement and prescribing patterns are supporting a transition from innovative therapy to standard-of-care use in multiple countries. As originator markets mature, regulatory frameworks and procurement policies are creating more room for generic participation and diversified supply strategies.

Looking ahead, the market is characterized by trends toward globalized production, compliance-oriented supply chains, and label expansion. With patent expirations approaching in certain regions, generic manufacturers are accelerating formulation programs, creating stronger demand for regulatory-grade APIs that meet multi-agency standards. Emerging research exploring additional gastrointestinal applications could expand clinical relevance. Advances in formulation technologies—such as controlled release, fixed-dose combinations, and stability-enhanced products—will influence API purity thresholds, impurity profiles, and release specifications, driving suppliers toward higher technological capabilities.

The primary market drivers include clinical demand, regulatory incentives and industrial upgrading. The chronic nature of gastrointestinal disorders and patient preference for safe, long-term therapies sustain usage. Policies that support high-value generics and improved formulations are shortening market entry cycles while intensifying requirements for API traceability and quality. CDMO-centric collaboration is accelerating, improving capacity flexibility and cost efficiency. Innovations in continuous synthesis and green chemistry are emerging as key levers for impurity control and cost reductions, raising competitive technical thresholds.

Challenges remain, concentrated in manufacturing complexity, regulatory pressure, cost structures and market concentration. Linaclotide requires multistep synthesis, complex protection/deprotection chemistry and demanding purification, resulting in high technical risks. Regulatory divergences among agencies, lengthy audits and the cost burden of DMF maintenance and equivalence assessments create compliance barriers. Cost pressures from raw materials, lyophilization and sterile packaging persist. With a high market concentration and established incumbents holding regulatory and customer-lock advantages, competition leans more toward long-term compliance and multi-market registration capability rather than price-driven entry.

This report studies and analyses global Linaclotide API status and future trends, helps the client to determine the Linaclotide API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Linaclotide API, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Linaclotide API market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Tons)
(2) Global Linaclotide API sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(3) China Linaclotide API sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(4) Global Linaclotide API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Linaclotide API key producing regions, capacity, production, and year over year growth
(6) Linaclotide API industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Piramal Pharma Solutions
    Neuland Labs
    TAPI
    ChemWerth
    Omgene Life Sciences
    BCN Peptides
    Aurobindo Pharma
    Zhejiang Peptites Biotech
    Suzhou Tianma Pharma Group
    Chinese Peptide Company
    Zhejiang Supor Pharmaceuticals
    Hybio Pharmaceutical
    ChengDu ShengNuo Biotec

Market segment by Type, covers
    High Purity
    Standard Purity

Market segment by Production Model, covers
    In-House Manufactured API
    CDMO Contract Production API
    Others

Market segment by Therapeutic Area, covers
    Chronic Constipation Treatment
    IBS-C Treatment
    Others

Market segment by Application, can be divided into
    Pharmaceutical Companies
    Research Institutes
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Linaclotide API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Linaclotide API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Linaclotide API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Linaclotide API, percent & CAGR, 2020-2031
Chapter 5: Linaclotide API industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.